Loading…

Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis

Background: auto-antibodies against the potassium channel inward rectifying potassium channel 4.1 (Kir4.1) have previously been identified in 46% of patients with multiple sclerosis (MS). Objectives: to confirm these findings. Methods: we evaluated the presence of anti-Kir4.1 antibodies by enzyme-li...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis 2014-11, Vol.20 (13), p.1699-1703
Main Authors: Nerrant, Elodie, Salsac, Céline, Charif, Mahmoud, Ayrignac, Xavier, Carra-Dalliere, Clarisse, Castelnovo, Giovanni, Goulabchand, Radjiv, Tisseyre, Julie, Raoul, Cédric, Eliaou, Jean-François, Labauge, Pierre, Vincent, Thierry
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: auto-antibodies against the potassium channel inward rectifying potassium channel 4.1 (Kir4.1) have previously been identified in 46% of patients with multiple sclerosis (MS). Objectives: to confirm these findings. Methods: we evaluated the presence of anti-Kir4.1 antibodies by enzyme-linked immunosorbent assay (ELISA) and immunofluorescence in 268 MS patients, 46 patients with other neurological diseases (OND) and 45 healthy controls. Results: anti-Kir4.1 antibodies were found in 7.5% of MS patients, 4.3% of OND patients and 4.4% of healthy controls. Immunofluorescence analysis did not identify any specific staining. Conclusions: we confirmed the presence of anti-Kir4.1 antibodies in MS patients, but at a much lower prevalence than previously reported.
ISSN:1352-4585
1477-0970
DOI:10.1177/1352458514531086